LH Quote, Financials, Valuation and Earnings

Danaher has a net margin of 4.31% compared to Labcorp Holdings's net margin of 16.61%. Labcorp Holdings's return on equity of 9.29% beat Danaher's return on equity of 7.57%.

Labcorp Holdings has a consensus price target of $273.60, signalling upside risk potential of 18.94%. On the other hand Danaher has an analysts' consensus of $265.19 which suggests that it could grow by 28.83%. Given that Danaher has higher upside potential than Labcorp Holdings, analysts believe Danaher is more attractive than Labcorp Holdings.

Labcorp Holdings has a beta of 1.122, which suggesting that the stock is 12.207% more volatile than S&P 500. In comparison Danaher has a beta of 0.823, suggesting its less volatile than the S&P 500 by 17.66%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.25%. Danaher offers a yield of 0.55% to investors and pays a quarterly dividend of $0.32 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Danaher pays out 19.7% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are smaller than Danaher quarterly revenues of $6.5B. Labcorp Holdings's net income of $143.4M is lower than Danaher's net income of $1.1B. Notably, Labcorp Holdings's price-to-earnings ratio is 26.08x while Danaher's PE ratio is 38.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.49x versus 6.36x for Danaher. Usually stocks with elevated PS ratios are considered overvalued.

Exact Sciences has a net margin of 4.31% compared to Labcorp Holdings's net margin of -121.19%. Labcorp Holdings's return on equity of 9.29% beat Exact Sciences's return on equity of -34.11%.

Labcorp Holdings has a consensus price target of $273.60, signalling upside risk potential of 18.94%. On the other hand Exact Sciences has an analysts' consensus of $68.89 which suggests that it could grow by 57.78%. Given that Exact Sciences has higher upside potential than Labcorp Holdings, analysts believe Exact Sciences is more attractive than Labcorp Holdings.

Labcorp Holdings has a beta of 1.122, which suggesting that the stock is 12.207% more volatile than S&P 500. In comparison Exact Sciences has a beta of 1.248, suggesting its more volatile than the S&P 500 by 24.844%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.25%. Exact Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Exact Sciences pays out -- of its earnings as a dividend. Labcorp Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are larger than Exact Sciences quarterly revenues of $713.4M. Labcorp Holdings's net income of $143.4M is higher than Exact Sciences's net income of -$864.6M. Notably, Labcorp Holdings's price-to-earnings ratio is 26.08x while Exact Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.49x versus 2.91x for Exact Sciences. Usually stocks with elevated PS ratios are considered overvalued.

Illumina has a net margin of 4.31% compared to Labcorp Holdings's net margin of 16.94%. Labcorp Holdings's return on equity of 9.29% beat Illumina's return on equity of -35.09%.

Labcorp Holdings has a consensus price target of $273.60, signalling upside risk potential of 18.94%. On the other hand Illumina has an analysts' consensus of $130.64 which suggests that it could grow by 63.31%. Given that Illumina has higher upside potential than Labcorp Holdings, analysts believe Illumina is more attractive than Labcorp Holdings.

Labcorp Holdings has a beta of 1.122, which suggesting that the stock is 12.207% more volatile than S&P 500. In comparison Illumina has a beta of 1.171, suggesting its more volatile than the S&P 500 by 17.134%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.25%. Illumina offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Illumina pays out -- of its earnings as a dividend. Labcorp Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are larger than Illumina quarterly revenues of $1.1B. Labcorp Holdings's net income of $143.4M is lower than Illumina's net income of $187M. Notably, Labcorp Holdings's price-to-earnings ratio is 26.08x while Illumina's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.49x versus 2.91x for Illumina. Usually stocks with elevated PS ratios are considered overvalued.

Waters has a net margin of 4.31% compared to Labcorp Holdings's net margin of 26.52%. Labcorp Holdings's return on equity of 9.29% beat Waters's return on equity of 43.99%.

Labcorp Holdings has a consensus price target of $273.60, signalling upside risk potential of 18.94%. On the other hand Waters has an analysts' consensus of $400.84 which suggests that it could grow by 10.84%. Given that Labcorp Holdings has higher upside potential than Waters, analysts believe Labcorp Holdings is more attractive than Waters.

Labcorp Holdings has a beta of 1.122, which suggesting that the stock is 12.207% more volatile than S&P 500. In comparison Waters has a beta of 0.997, suggesting its less volatile than the S&P 500 by 0.345%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.25%. Waters offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Waters pays out -- of its earnings as a dividend. Labcorp Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are larger than Waters quarterly revenues of $872.7M. Labcorp Holdings's net income of $143.4M is lower than Waters's net income of $231.4M. Notably, Labcorp Holdings's price-to-earnings ratio is 26.08x while Waters's PE ratio is 33.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.49x versus 7.29x for Waters. Usually stocks with elevated PS ratios are considered overvalued.